TAPIMMUNE INC (TPIV)

TapImmune Inc. engages in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. The company focuses on conducting studies using its transporters of antigen processing (TAP) gene technology in combination with an adeno virus. Its products include TAP cancer vaccine, which is under preclinical trial used for the treatment of breast cancer, prostate cancer, lung cancer, liver cancer, melanoma, renal cancer, and colorectal cancer. The company was founded in 1999 and is based in Seattle, Washington.

LATEST ARTICLES

After TapImmune, Inc. (OTCMKTS:TPIV) experienced a tough year in 2014 in which it lost more than 90% of its value and continued to slide down the charts in the first month of 2015 it reached a 52-week low of $0.124.
read more

2014 was not a great year for the stock of TapImmune Inc. (OTCMKTS:TPIV). In fact, you could say that it was pretty disastrous - back in March the stock passed through $5.5 per share while by the end of December it found itself below 30 cents. The sta...
read more

On Monday TapImmune Inc. (OTCMKTS:TPIV) announced a $1.46 million direct offering. The company sold 7,320,000 units priced at $0.20 each. One unit consisted of 1 share and 5 warrants (one of each Series A, B, C, D and E). The exercise prices of the warr...
read more

TapImmune Inc. (OTCMKTS:TPIV) as its name shows is an immunotherapy pennystock company that is developing vaccines for cancer and infectious diseases. Last year the company performed two Phase 1 clinical trials in Breast and Ovarian cancer and announced...
read more

LATEST STOCK PROMOTIONS

Our Pick TPIV
Dear Valued Subscriber,
I AM ALERTING TPIV FOR TOMORROW!!!!!
TapImmune is a clinical-stage immunotherapy specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Unlike other vaccine technologies that narrowly address the initiation of an immune
read more

V.I.P STOCK ALERTS
Attention V.I.P. Traders...
Put TPIV on your radar NOW!
I feel like I owe you all a little make up after Tuesday's pick gapped down even before the open, thus ruining any reason for us to even play this time around.
Now, when I say make-up... I mean a "HOLY SH*T, lets give our subscribers something to talk about!"
read more

ATTENTION HUNTERS!
Put TPIV on your radar NOW!
I feel like I owe you all a little make up after Tuesday's pick gapped down even before the open, thus ruining any reason for us to even play this time around.
Now, when I say make-up... I mean a "HOLY SH*T, lets give our subscribers something to talk about!" kind of make-up.
So
read more